跳至主要内容
临床试验/NCT02246153
NCT02246153Unknown3 期

Morbidity and Mortality of Laparoscopy-assisted and Open Distal Gastrectomy for Gastric Cancer in the Elderly Patients: A Randomized Controlled Trial

Nanfang Hospital, Southern Medical University1 个研究点 分布在 1 个国家目标入组 202 人开始时间: 2014年9月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
入组人数
202
试验地点
1
主要终点
Postoperative complication rate

研究概览

简要总结

  • Laparoscopy-assisted distal gastrectomy for the treatment of early gastric cancer (EGC) has been supported by high-quality evidence, and the high-level evidence for advanced gastric cancer based on large prospective randomized controlled trial as CLASS-01、JCOG 0901, KLASS -02 is still awaited.Hopefully, it would have also gained the solid evidence of laparoscopy-assisted distal gastrectomy for the treatment of advanced gastric cancer (AGC).
  • China has entered the aging society since 1999. Among the GC patients in China, the average age is 65 years old, which makes increasing attempts to explore laparoscopic techniques in the treatment of elderly patients.
  • Nowadays, a considerable proportion of elderly patients suffer from multiple diseases, such as hypertension, diabetes, coronary heart disease. Thus the risk of intraoperative and postoperative complications can not be ignored. Unfortunately, there are rare studies specializing into the LAG for the GC patients of > 65 years old.
  • Accordingly, the comparison of intraoperative and postoperative complications between laparoscopy-assisted and open distal gastrectomy for over 65 years old patients with gastric cancer based on a randomized controlled trial is warranted.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age over 65 years
  • •Primary gastric adenocarcinoma (papillary, tubular, mucinous, signet ring cell, or poorly differentiated) confirmed pathologically by endoscopic biopsy
  • •cT1-4a, N0-3, M0 at preoperative evaluation according to the AJCC Cancer Staging Manual Seventh Edition
  • •Expected curative resection through distal subtotal gastrectomy with D2 lymphadenectomy
  • •Performance status of 0 or 1 on ECOG (Eastern Cooperative Oncology Group) scale
  • •ASA (American Society of Anesthesiology) score class I, II, or III
  • •Written informed consent

排除标准

  • •Severe mental disorder
  • •History of previous upper abdominal surgery (except laparoscopic cholecystectomy)
  • •History of previous gastrectomy, endoscopic mucosal resection or endoscopic submucosal dissection
  • •Exclude the early gastric cancer feasible for ESD
  • •Enlarged or bulky regional lymph node diameter over 3cm by preoperative imaging
  • •History of other malignant disease within past five years
  • •History of previous neoadjuvant chemotherapy or radiotherapy
  • •History of unstable angina or myocardial infarction within past six months
  • •History of cerebrovascular accident within past six months
  • •History of continuous systematic administration of corticosteroids within one month
  • •Requirement of simultaneous surgery for other disease
  • •Emergency surgery due to complication (bleeding, obstruction or perforation) caused by gastric cancer
  • •FEV1<50% of predicted values

研究组 & 干预措施

Laparoscopic gastrectomy

Experimental

Laparoscopy-assisted distal gastrectomy with D2 lymphadenectomy will be performed for the treatment of patients assigned to this group.

干预措施: Laparoscopic gastrectomy (Procedure)

Open gastrectomy

Active Comparator

Open distal gastrectomy with D2 lymphadenectomy will be performed for the treatment of patients assigned to this group.

干预措施: Open gastrectomy (Procedure)

结局指标

主要结局

Postoperative complication rate

时间窗: 30 days

30 day morbidity and mortality

次要结局

  • Postoperative recovery index(7 days)
  • Postoperative pulmonary complications(30 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Guoxin Li

M.D.,Ph.D., F.R.C.S.

Nanfang Hospital, Southern Medical University

研究点 (1)

Loading locations...

相似试验